Transition Therapeutics Inc (NASDAQ:TTHI)

7.90
Delayed Data
As of Apr 17
 +0.20 / +2.60%
Today’s Change
4.36
Today|||52-Week Range
8.00
+15.55%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close7.70
Today’s open7.65
Day’s range7.60 - 8.00
Volume81,136
Average volume (3 months)21,182
Market cap$279.0M
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)-62.21%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book5.03

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd+0.04+0.24%
OXFDOxford Immunotec Glo...-0.58-4.10%
CALACalithera Bioscience...-0.32-1.71%
TROVTrovagene Inc+1.43+20.14%
Data as of 3:59pm ET, 04/17/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers